obsessive compulsive disorder. Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: Intervention group: Injecting Tryptrolin 3.75 mg three times a day, at the beginning of the study and one month later and two months respectively. Intervention 2: Control group: Inject
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: diagnosis of obsessive-compulsive disorders based on DSM-V criteria aged 18-64 years completed consent form by he patient or his family at least eight grade education Obsessive-compulsive patients who have received at least eight weeks of adequate SSRI treatment and, if necessary, benzodiazepine or anti-psychotic that does not affect the level of the gonadal hormones And the yele Brown score is above 17
Exclusion criteria
Exclusion criteria: simultaneous psychiatric disorders liver disorders use of opioid substance other than cigarttes A hypersensitivity reaction or any untoward side effects caused by the drug use of other interfering drug Any contraindications for tryptorelin such as pregnancy or lactation or bone diseases that are taken from patients during the initial history. medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Obsession compulsion symptoms in yel brown questionnaire. Timepoint: Before starting the study and at times, 0,1, 2 and 4 month after starting treatment. Method of measurement: obsession symptoms assessment questionnaire yele-brown.;Clinical symptoms of obsession. Timepoint: Before starting the study and at times, 0,1, 2 and 4 month after starting. Method of measurement: clinical interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaezeh Nikzad
Mashhad University of Medical Sciences
Outcome results
None listed